BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6761866)

  • 1. Ifosfamide: European perspective.
    Burkert H
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):28-35. PubMed ID: 6761866
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide--pharmacology, safety and therapeutic potential.
    Brade WP; Herdrich K; Varini M
    Cancer Treat Rev; 1985 Mar; 12(1):1-47. PubMed ID: 3896483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary evaluation of the effectiveness of holoxan in the treatment of malignant soft tissue and bone neoplasms].
    Utracka-Hutka B; Czownicki Z
    Nowotwory; 1981; 31(2):147-53. PubMed ID: 7038629
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide vs cyclophosphamide in cancer therapy.
    Weiss RB
    Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with the cytostatic drug ifosfamide].
    Ritter S; Schröder HJ
    Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737
    [No Abstract]   [Full Text] [Related]  

  • 6. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 7. Ifosfamide.
    Zalupski M; Baker LH
    J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticancer spectrum of ifosfamide.
    Hunter HL; Harrison EF
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):96-100. PubMed ID: 6761868
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a cooperative clinical study of the cytostatic agent ifosfamide.
    Schnitker J; Brock N; Burkert H; Fichtner E
    Arzneimittelforschung; 1976; 26(10):1783-92. PubMed ID: 798586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in experimental tumor systems.
    Goldin A
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):14-23. PubMed ID: 6761864
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in prevention of the recurrence of resectable cancer.
    Bonadonna G; Tancini G; Rossi A; Gasparini M
    Annu Rev Med; 1978; 29():149-75. PubMed ID: 206184
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies with ifosfamide in patients with malignant lymphoma.
    Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
    Stuart-Harris R; Harper PG; Kaye SB; Wiltshaw E
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():163-4. PubMed ID: 6414689
    [No Abstract]   [Full Text] [Related]  

  • 14. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
    Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory malignant neoplasms with ifosfamide as single agent and in combination chemotherapy.
    Retsas S
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():151-7. PubMed ID: 6627241
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
    Blackledge G; Steward WP; Verweij J; Mouridsen H; Bramwell V; Schütte J; van Oosterom A; Dombernowsky P; Buesa J; Van Glabekke M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):14-8. PubMed ID: 1411615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
    Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
    Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.
    Demetri GD
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Morgan LR; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):56-60. PubMed ID: 6298944
    [No Abstract]   [Full Text] [Related]  

  • 20. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.